Chiropractor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

David Glick

Chiropractor, Neurology Richmond, VA Chiropractor

NPI 1073651725 CMS profile 934793

7329 Boulder View Ln, Richmond, VA 23225

Open in the dashboard

General payments

$7,361

35 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, David Glick of Richmond, VA is reported in the CMS Open Payments database as having received $7,361 across 35 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $248 1
2023 General $83 2
2022 General $533 7
2021 General $245 5
2020 General $5,542 15
2019 General $709 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Glick
  • Chiropractor, Neurology median
  • Middle half of Chiropractor, Neurology
  • National median

In program year 2025, general payments to David Glick were reported at $0. Among 24 Chiropractor, Neurology profiles paid that year, the median was $122 and the middle half received between $39 and $154.

Show as a table
Year David Glick Chiropractor, Neurology median Middle half National median
2019 $709 $93 $24–$196 $163
2020 $5,542 — — $114
2021 $245 — — $132
2022 $533 $131 $64–$216 $149
2023 $83 — — $160
2024 $248 — — $164
2025 $0 $122 $39–$154 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Atricure, Inc. $6,114 18 payments
  2. GRT US Holding, Inc. $364 6 payments
  3. Tonix Pharmaceuticals, Inc. $248 1 payment
  4. Biodelivery Sciences International, Inc. $150 2 payments
  5. Stryker Corporation $135 1 payment
  6. Averitas Pharma Inc. $83 2 payments
  7. Vertos Medical, Inc. $78 1 payment
  8. Pfizer Inc. $63 1 payment
  9. Collegium Pharmaceutical, Inc. $54 1 payment
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $54 1 payment
  11. Other $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $4,500 3 payments
  2. Travel and Lodging $1,585 11 payments
  3. Food and Beverage $1,276 21 payments
Products named General payments · program years 2019–2024
  1. ATRICURE ATRICLIP LAA EXCLUSION $5,542 15 payments
  2. Qutenza $338 7 payments
  3. ZEMBRACE SYMTOUCH $248 1 payment
  4. SPINEJACK $135 1 payment
  5. mild Device Kit $78 1 payment
  6. BELBUCA Chronic Pain $76 1 payment
  7. SYMPROIC $76 1 payment
  8. BELBUCA Addiction Therapy $73 1 payment
  9. ELYXYB - celecoxib $54 1 payment
  10. RELISTOR $54 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

35 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Chiropractor, Neurology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record